LifeWatch AG

EANS-Adhoc: LifeWatch contracts with an additional 41 Payors for ACT and Home Sleep Testing in Q1 2012 (with document)

Ein Dokument

--------------------------------------------------------------------------------
  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
--------------------------------------------------------------------------------
Contracts/LifeWatch AG

02.05.2012

Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE),
the leading wireless remote cardiac and medical patient monitoring service
provider in the U.S., announced today that it has contracted with 20 new
providers for its ACT Ambulatory Cardiac Telemetry services and a further 21 new
providers for its Home Sleep testing services during the first quarter of 2012.
Collectively, the new agreements represent over 71 million covered lives.

You will find a PDF-version of this press release at the end of this message.

LifeWatch continues its vigorous pursuit to increase its portfolio of contracted
payors across the nation for all of its service lines. Of notable mention are
the following contracts completed in Q1 2012:

+ United HealthCare (UHC) and all of its affiliates: 

Completed a major new follow-on national agreement as an In-Network Preferred
Provider providing coverage of our standard cardiac event monitoring and home
sleep testing services to approximately 70 million members. Specifically and
importantly this contract added the availability of LifeWatch's NiteWatch home
sleep test  to the UHC nationwide network of 595,000 physicians and other health
care professionals. LifeWatch is also the sole In-Network provider for UHC's
Medicare members for ambulatory cardiac telemetry (ACT).

+ Prime/NAMM: 

Contracted for cardiac monitoring services including ACT to their 205,000
members. NAMM develops and manages provider networks in California, with a
client network of over 600 primary care physicians, 1,200 specialists and
premier hospitals.

+ Dimension Health PPO: 

Contracted with South Florida's largest Preferred Provider Organization(PPO)
Network for Home Sleep Test services for covering approximately 400,000 lives.
Dimension Health is a high quality, cost effective, community based network that
insurers, employers, unions and government sponsored health programs provide to
their employees.

+ Fidelis Care of NY: 

Contracted for all LifeWatch service lines to provide coverage to its more than
725,000 Managed Medicaid and dual-eligible Medicare enrollees in 58 counties,
making them the largest government programs-based health insurance company in
New York State.

"LifeWatch continues to prove to providers the value of our cost effective
health monitoring services," stated Dr. Yacov Geva, Chairman and CEO of
LifeWatch AG, which is the parent company of LifeWatch Services, Inc. "These
new contracts corroborate our momentum in obtaining important coverage and
payment contracts and that the market is starting to shift from Sleep Labs to
the more cost effective non-attended home sleep testing".


About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss
Exchange (LIFE), Switzerland, is the leading healthcare technology and solution
company, specializing in advanced telehealth systems and wireless remote patient
monitoring services. LifeWatch services cater to individuals, ranging from
high-risk and chronically ill patients, to consumers of health and wellness
products. LifeWatch has subsidiaries in the United States, the Netherlands,
Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent
company of LifeWatch Services Inc., a leading US-based cardiac monitoring
service provider, and manufacturer of telecardiology products. LifeWatch is also
introducing a new program for Home Sleep Testing of Obstructive Sleep Apnea
(OSA) patients under the brand name NiteWatch. For additional information,
please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is available at
http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking statements. All statements other
than statements of historical facts contained in this press release, including
statements regarding future results of operations and financial position,
business strategy and plans and objectives for future operations, are
forward-looking statements. The words "believe," "may," "will," "estimate,"
"continue,""anticipate," "intend," "expect" and similar expressions are intended
to identify forward-looking statements. LifeWatch AG has based these
forward-looking statements largely on current expectations and projections about
future events and financial trends that it believes may affect the financial
condition,  results of operations, business strategy, short term and long-term
business operations and objectives, and financial needs. These forward-looking
statements are subject to a number of risks, uncertainties and assumptions. In
light of these risks, uncertainties and assumptions, the forward-looking events
and circumstances described may not occur and actual results could  differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only on
data available to LifeWatch AG at the time of the issue of this press release.
LifeWatch AG does not undertake any obligation to update any forward-looking
statements contained in this press release as a result of  enw information,
future events or otherwise.


THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT
CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES
FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN
ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD
OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION
UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE
UNITED STATES SECURITIES LAWS.  ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN
THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED
FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS  MANAGEMENT AS WELL AS FINANCIAL STATEMENTS
OF THE ISSUER.

Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/LZrurKZz

Further inquiry note:
Sensus Investor and Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


Attachments with Announcement:
----------------------------------------------
http://resources.euroadhoc.com/us/LZrurKZz


issuer:      LifeWatch AG
             Rundbuckstrasse 6
             CH-8212 Neuhausen am Rheinfall
phone:       +41 52 632 00 50
FAX:         +41 52 632 00 51
mail:     users@lifewatch.com
WWW:      www.lifewatch.com
sector:      Healthcare Providers
ISIN:        CH0012815459
indexes:     SPI, SPIEX
stockmarkets: free trade: Berlin, Open Market / XETRA: Frankfurt, Main Standard:
             SIX Swiss Exchange 
language:   English
 



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: